相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Androgen Receptor Rearrangement and Splicing Variants in Resistance to Endocrine Therapies in Prostate Cancer
Yeung Ho et al.
ENDOCRINOLOGY (2017)
Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action
Fuqiang Ban et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Cheminformatics Modeling of Adverse Drug Responses by Clinically Relevant Mutants of Human Androgen Receptor
Naman Paul et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting
E. S. Antonarakis et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
Nada Lallous et al.
GENOME BIOLOGY (2016)
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A. Azad et al.
CLINICAL CANCER RESEARCH (2015)
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer (vol 289, pg 26417, 2014)
Kush Dalal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer
Zhenfei Li et al.
NATURE (2015)
Switching and withdrawing hormonal agents for castration-resistant prostate cancer
David Lorente et al.
NATURE REVIEWS UROLOGY (2015)
Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer
Ravi S. N. Munuganti et al.
CHEMISTRY & BIOLOGY (2014)
Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif
Katja Jehle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
Huifang Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of 1H-Indole-2-carboxamides as Novel Inhibitors of the Androgen Receptor Binding Function 3 (BF3)
Fuqiang Ban et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
New potent inhibitors of the androgen receptor that target its BF3 surface binding site.
Ravi Munuganti et al.
CANCER RESEARCH (2013)
Progress in emerging therapies for advanced prostate cancer
Stephane Oudard
CANCER TREATMENT REVIEWS (2013)
Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole Derivatives
Ravi Shashi Nayana Munuganti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer
Preethi Ravindranathan et al.
NATURE COMMUNICATIONS (2013)
Overcoming mutation-based resistance to antiandrogens with rational drug design
Minna D. Balbas et al.
ELIFE (2013)
True Antiandrogens-Selective Non-Ligand-Binding Pocket Disruptors of Androgen Receptor-Coactivator Interactions: Novel Tools for Prostate Cancer
Laura Caboni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Inhibitors of Androgen Receptor Activation Function-2 (AF2) Site Identified through Virtual Screening
Peter Axerio-Cilies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor through Virtual Screening
Nathan A. Lack et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor
X. Edward Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
A surface on the androgen receptor that allosterically regulates coactivator binding
Eva Estebanez-Perpina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
eHiTS: A new fast, exhaustive flexible ligand docking system
Zsolt Zsoldos et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2007)
Fast 3D shape screening of large chemical databases through alignment-recycling
Fabien Fontaine et al.
CHEMISTRY CENTRAL JOURNAL (2007)
Structural basis for accommodation of nonsteroidal ligands in the androgen receptor
CE Bohl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
CE Bohl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Surflex: Fully automatic flexible molecular docking using a molecular similarity-based search engine
AN Jain
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Mechanism of antiandrogen action:: Key role of Hsp90 in conformational change and transcriptional activity of the androgen receptor
V Georget et al.
BIOCHEMISTRY (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
分享论文
